# The Differential Involvement of α1-Adrenoceptor Subtypes in the Molecular Effects of Antidepressant Drugs

**Authors:** Irena Nalepa, Katarzyna Chorązka, Grzegorz Kreiner, Agnieszka Zelek-Molik, Anna Haduch, Władysława Anna Daniel, Piotr Chmielarz, Katarzyna Maziarz, Justyna Kuśmierczyk, Michał Wilczkowski, Adam Bielawski, Marta Kowalska

PMC · DOI: 10.3390/ijms262110488 · International Journal of Molecular Sciences · 2025-10-28

## TL;DR

This study explores how different alpha-1 adrenergic receptor subtypes affect the molecular actions of antidepressants in mice brains.

## Contribution

The study reveals functional differences between α1-adrenergic receptor subtypes in antidepressant drug mechanisms.

## Key findings

- Deletion of α1D subtype mainly reduced milnacipran's chronic effects on transcriptomic and proteomic levels.
- The effects of antidepressants varied by gender in molecular responses.
- α1-AR subtype knockout did not alter α2- or β-AR densities in the mouse brain.

## Abstract

We investigated whether the functional involvement of α1-adrenergic receptors (α1-AR) in the effects induced by antidepressant drugs, desipramine, and milnacipran varies depending on the α1-AR subtype. First, using a mouse line with triple knockout (KO) of genes encoding all three α1-AR subtypes (ABD-KO) and autoradiographic analysis, we demonstrated that the inactivation of α1-AR did not affect the density of other types of adrenergic receptors, α2- and β-AR in the mouse brain. Subsequently, we utilized three mouse knockout lines with selective knockout of the gene encoding a single α1-adrenergic receptor subtype (A-KO, B-KO, and D-KO). We analyzed the impact of these mutations on tissue levels of monoaminergic neurotransmitters in the hypothalamus (HY). Next, we assessed how a specific mutation affects the chronic effects of desipramine and milnacipran in the selected brain regions of male and female mice at various molecular levels: mRNA expression of genes encoding for α1-AR subtypes, gene expression profiling, and phosphorylation of selected signaling proteins (ERK1/2, Akt, GSK3β). The main finding is that the deletion of the α1D subtype predominantly reduced the chronic effects of milnacipran at the examined transcriptomic and proteomic levels. The pattern of changes differed by gender. Our study revealed the functional diversity between α1-AR subtypes in the molecular mechanisms of antidepressants’ drug action.

## Linked entities

- **Genes:** Adora1 (adenosine A1 receptor) [NCBI Gene 11539], Adra1d (adrenergic receptor, alpha 1d) [NCBI Gene 11550], erk1/2 (mitogen-activated protein kinase) [NCBI Gene 778596], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932]
- **Proteins:** Adora1 (adenosine A1 receptor), ADORA2A (adenosine A2a receptor), ADRB2 (adrenoceptor beta 2), erk1/2 (mitogen-activated protein kinase), AKT1 (AKT serine/threonine kinase 1), GSK3B (glycogen synthase kinase 3 beta)
- **Chemicals:** desipramine (PubChem CID 2995), milnacipran (PubChem CID 65833)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Adra1d (adrenergic receptor, alpha 1d) [NCBI Gene 11550] {aka Adra-1, Adra1, Adra1a, Gpcr8, Spr8, [a]1d}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}
- **Chemicals:** desipramine (MESH:D003891), milnacipran (MESH:D000078764)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12610789/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12610789/full.md

## References

126 references — full list in the complete paper: https://tomesphere.com/paper/PMC12610789/full.md

---
Source: https://tomesphere.com/paper/PMC12610789